l-lysine methyl ester has been researched along with Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, R; Deng, C; Meng, F; Xie, F; Zhang, J; Zhong, Y; Zhong, Z | 1 |
1 other study(ies) available for l-lysine methyl ester and Breast Cancer
| Article | Year |
|---|---|
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Chemistry, Pharmaceutical; Cross-Linking Reagents; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Injections, Intravenous; Lysine; MCF-7 Cells; Mice, Nude; Molecular Targeted Therapy; Nanomedicine; Nanoparticles; Solubility; Technology, Pharmaceutical; Thioctic Acid; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |